| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9268739 | Journal of Clinical Virology | 2005 | 6 Pages |
Abstract
The validity of the QA programme was established and reproducibility in different lab settings was reassuring. These results support the use of hc2 as a potential screening test in diagnostic laboratories. The need for robust quality assurance of HPV testing in cervical screening programmes was confirmed and lessons learnt from this pilot study will be incorporated in future schemes.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Heather A. Cubie, Catherine Moore, Michael Waller, Sue Moss, on behalf of the National Cervical Screening Committee LBC/HPV Pilot Steering Group on behalf of the National Cervical Screening Committee LBC/HPV Pilot Steering Group,